Regulation of avidity in T lymphocytes
T 淋巴细胞亲合力的调节
基本信息
- 批准号:9199573
- 负责人:
- 金额:$ 19.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaAvidityCD8-Positive T-LymphocytesCD8B1 geneCell Differentiation processCell divisionCell physiologyCellsCytokine ReceptorsCytokine SignalingDataDevelopmentDoseEffector CellEpigenetic ProcessEventGene ExpressionGene Expression RegulationGoalsImmuneImmunotherapeutic agentIndividualInfectionInterferon Type IIInterleukin-4InvestigationKineticsLaboratoriesLeadMaintenanceMeasuresMethylationModelingModificationMolecularNational Institute of Allergy and Infectious DiseasePeptide/MHC ComplexPeptidesPerfumePositioning AttributeProcessProductionPropertyRegulationResearch PersonnelRoleShapesSignal TransductionSystemT cell regulationT cell responseT-LymphocyteTestingVaccine DesignVirus DiseasesWorkautocrinebasecell injurycytokinedesignepigenetic regulationimprovedin vivoinnovationinsightmethylation patternneoplastic cellnovelnovel therapeutic interventionprogramspublic health relevancereceptor expressionresponsetranscription factortumortumor eradication
项目摘要
DESCRIPTION (provided by applicant): It is increasingly clear that T cell fate is the result of a multi-faceted and highly regulated process of differentiation. This process dictates multiple properties of the cell including the range of effector functions, survival, and functional avidity.
Functional avidity is a fundamental determinant of in vivo efficacy. At present, we are far from a complete understanding of the molecular control of avidity. Our previous results demonstrated that an individual T cell can modulate avidity in response to the stimulatory signal. The overall goals of the studies presented here are to determine the mechanism by which CD8+ T cells modulate avidity, and the epigenetic changes associated with determination of the avidity set point. Aim 1. To define the regulation of IL-4 and IFNγ production and signaling as a result of engagement of high versus low peptide. Our preliminary data support the hypothesis that avidity modulation in CD8+ T cells is regulated by the combined effects of T cell derived IL-4 and IFNγ. We propose that encounter with high vs. low amounts of peptide/MHC results in divergence in cytokine production by T cells and/or their responsiveness to these cytokines. This model is innovative in that it suggests an autocrine cytokine based self tuning of avidity. Our studies will
test the hypothesis that these individual cytokines are produced at distinct levels or with differet kinetics depending on the amount of peptide/MHC present. We will also test the hypothesis that cytokine receptor expression and/or responsiveness is differentially regulated in cells that are differentiating into high vs. low avidity effectors. Aim 2. To determine how cytokine and TCR signals induce epigenetic changes in cells undergoing functional avidity modulation. Epigenetic changes result in maintenance of gene expression programs through cell division, consistent with the stable functional avidity set point induced in effector cells in our system. Recent studie demonstrate the critical role of methylation in programming differentiation of CD8+ effector cells.
We believe these results provide strong rationale for examining the role or methylation in establishing the avidity set point. These studies will provide novel information regarding the control of functional avidity in differentiating CD8+ T cells. The results from these studies may ultimately open the door to new therapeutic interventions aimed at manipulating T cell responses in vivo.
描述(由申请人提供):越来越清楚的是,T 细胞命运是多方面且高度调控的分化过程的结果,该过程决定了细胞的多种特性,包括效应器功能范围、存活和功能亲和力。 。
功能性亲和力是体内功效的基本决定因素,目前,我们还远未完全了解亲和力的分子控制。本文介绍的研究旨在确定 CD8+ T 细胞调节亲和力的机制,以及与亲和力设定点确定相关的表观遗传变化。 目标 1. 定义 IL-4 和 IFNγ 的调节。我们的初步数据支持这样的假设:CD8+ T 细胞的亲和力调节是由 T 细胞衍生的 IL-4 和 IFNγ 的联合作用调节的。低含量的肽/MHC 导致 T 细胞产生细胞因子和/或它们对这些细胞因子的反应的差异,因为它表明我们的研究将基于自分泌细胞因子的自调节。
检验以下假设:根据肽/MHC 的存在量,这些单独的细胞因子以不同的水平或不同的动力学产生。我们还将检验细胞因子受体表达和/或反应性在分化为高水平的细胞中受到差异性调节的假设。目标 2. 确定细胞因子和 TCR 信号如何在经历功能亲和力调节的细胞中诱导表观遗传变化,从而通过细胞分裂维持基因表达程序,与稳定的功能一致。最近的研究证明了甲基化在 CD8+ 效应细胞的编程分化中的关键作用。
我们相信这些结果为检查甲基化在建立亲和力设定点中的作用提供了强有力的理论基础,这些研究将提供有关分化 CD8+ T 细胞的功能亲和力控制的新信息。这些研究的结果可能最终为新的研究打开大门。治疗干预旨在操纵体内 T 细胞反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martha Ann Alexander-Miller其他文献
Martha Ann Alexander-Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martha Ann Alexander-Miller', 18)}}的其他基金
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应
- 批准号:
10456073 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应
- 批准号:
10229523 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8668895 - 财政年份:2012
- 资助金额:
$ 19.06万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8840143 - 财政年份:2012
- 资助金额:
$ 19.06万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8319130 - 财政年份:2012
- 资助金额:
$ 19.06万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8477124 - 财政年份:2012
- 资助金额:
$ 19.06万 - 项目类别:
Cellular Immune Responses to Respiratory Infection
对呼吸道感染的细胞免疫反应
- 批准号:
7204197 - 财政年份:2004
- 资助金额:
$ 19.06万 - 项目类别:
Cellular Immune Responses to Respiratory Infection
对呼吸道感染的细胞免疫反应
- 批准号:
6780530 - 财政年份:2004
- 资助金额:
$ 19.06万 - 项目类别:
相似国自然基金
多区域环境因素复杂暴露反应关系的空间联合估计方法研究
- 批准号:82373689
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
区域出口产品升级的时空格局及机制研究——以粤港澳大湾区为例
- 批准号:42301182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多入口下穿隧道合流区域交通事故演化机理与自解释调控方法
- 批准号:52302437
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
应对多重不确定性的区域综合能源系统分布渐进调度理论研究
- 批准号:52377108
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
异质性视角下稻米区域公用品牌价值攀升协同治理机制研究
- 批准号:72373129
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
相似海外基金
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
临床就绪的 MACH-1 基因枪,用于提供通用流感 DNA 疫苗
- 批准号:
10761364 - 财政年份:2023
- 资助金额:
$ 19.06万 - 项目类别:
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
$ 19.06万 - 项目类别:
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
$ 19.06万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 19.06万 - 项目类别: